LIPELLA PHARMACEUTICALS INC (LIPOXXXX)
Institutional ownership reported to the SEC as of Q3 2024, across 8 quarters.
4
Reporting holders
$31.7K
Reported value
0.0%
Held as options
-3
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | $16.3K | 34,520 | 0.00% | 7q | HELD |
| GEODE CAPITAL MANAGEMENT, LLC | $11.8K | 24,915 | 0.00% | 4q | -4.2% |
| Tower Research Capital LLC (TRC) | $3.6K | 7,694 | 0.00% | 7q | HELD |
| BANK OF AMERICA CORP /DE/ | $22 | 47 | 0.00% | 2q | +2.2% |
| HRT FINANCIAL LP | $8 | 17,619 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2024 | 4 | $31.7K | 67,176 | 0 | 1 | 1 | 0.0% |
| Q2 2024 | 7 | $284.0K | 630,291 | 2 | 1 | 2 | 0.0% |
| Q1 2024 | 8 | $253.1K | 369,462 | 2 | 2 | 2 | 0.0% |
| Q4 2023 | 7 | $377.4K | 370,013 | 3 | 3 | 0 | 0.0% |
| Q3 2023 | 4 | $59.5K | 39,640 | 0 | 2 | 1 | 0.0% |
| Q2 2023 | 4 | $82.5K | 38,556 | 0 | 2 | 2 | 0.0% |
| Q1 2023 | 5 | $99.7K | 51,136 | 4 | 0 | 1 | 0.0% |
| Q4 2022 | 2 | $44.7K | 14,086 | 2 | 0 | 0 | 0.0% |